“ECONOMIC EVALUATION OF CYP2C19 GENOTYPE-GUIDED ANTIPLATELET THERAPY FOR PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A SYSTEMATIC REVIEW”, GLOBEHEAL, vol. 9, no. 01, pp. 14–30, Jun. 2026, doi: 10.17501/26138417.2026.9102.